Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Pacira Pharmaceuticals Inc. logo

Pacira Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

Optionable: Yes  Market Cap: 1,277 M  90-day average vol: 496,702

Previous close: 27.81  Open: 27.89  Bid: 23.0  Ask: 40.94
52 week range    
ABC / 
Last updated: Tuesday 5th December 2023
MarketXLS Rank

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


PCRX Income Statement

Amortization-6 M-5 M-4 M-4 M-10 M-13 M6 M8 M14 M57 M
Amortization of intangibles-2 M-800000.0-300000.0-100000.06 M8 M14 M57 M
Basic EPS from continuing operations3.410.950.35
Basic EPS total-0.36-0.390.05-1.02-1.07-0.273.410.950.35
Basic weighted shares outstanding33 M35 M37 M37 M40 M41 M42 M43 M44 M46 M
Cost of sales-55 M-77 M-72 M-110 M-88 M-87 M-107 M5 M43 M11 M
Depreciation-4 M-9 M-11 M-13 M-14 M-13 M-14 M-12 M-15 M-34 M
Depreciation unreconciled6 M8 M14 M57 M
DepreciationAndAmortization-4 M-9 M-11 M-13 M-14 M-13 M6 M8 M14 M57 M
Diluted EPS total-1.93-0.390.04-1.02-1.07-0.01-0.273.330.920.34
Diluted normalized net income/share3.330.920.34
Diluted weighted shares outstanding33 M35 M41 M37 M40 M41 M42 M44 M46 M47 M
GainOnSaleOfSecurity900000.06 M0.0
GainsLossOnDisposalOfDiscontinuedOperations-5 M-2 M
GeneralAndAdministrativeExpense-5 M-5 M-6 M-6 M-7 M-9 M-8 M194 M199 M255 M
Gross operating profit31 M120 M177 M166 M199 M-84 M-132 M424 M499 M656 M
Income before tax-64 M-14 M2 M-38 M-42 M-425000.0-11 M20 M56 M13 M
Income restructuring and M&A-303000.0-100000.0-847000.00.0
Income taxes-442000.0173000.0264000.0105000.0140000.046000.0268000.0-125 M14 M-3 M
Interest income259000.0382000.0678000.01 M4 M6 M7 M5 M896000.05 M
InterestExpenseNonOperating7 M8 M8 M7 M18 M22 M24 M26 M32 M40 M
InterestExpenseOperating-8 M-8 M-10 M-37 M
MiscOtherSpecialCharges-3 M-159000.0-217000.0-82000.0-4 M333 M416 M-5 M-3 M-11 M
Net income from total operations-64 M-14 M2 M-38 M-43 M-471000.0-11 M146 M42 M16 M
NetIncomeCommonStockholders-64 M-14 M2 M-38 M-43 M-471000.0-11 M146 M42 M16 M
NetIncomeContinuousOperations-64 M-14 M2 M-38 M-43 M-471000.0-11 M146 M42 M16 M
NetIncomeDiscontinuousOperations-5 M2 M200000.0200000.0
NetNonOperatingInterestIncomeExpense-7 M-8 M-7 M-6 M-14 M-15 M-16 M-21 M-31 M-35 M
NonRecurringOperationExpense-3 M0.00.0
Operating income-54 M-5 M9 M-32 M-20 M-318 M-411 M164 M90 M259 M
Operating income before depreciation (EBITDA)-47 M9 M26 M-13 M1 M49 M40 M78 M133 M115 M
OperatingExpense-139 M-203 M-240 M-308 M-312 M-321 M279 M261 M409 M397 M
Other income net3 M159000.0217000.082000.04 M-333 M-416 M123 M3 M11 M
OtherGandA-5 M-5 M-6 M-6 M-7 M-9 M-8 M194 M199 M255 M
OtherImpairmentOfCapitalAssets140 M-26 M
OtherOperatingExpenses623000.0323000.071000.0-308 M-312 M2 M-6 M-10 M-12 M-14 M
OtherWriteOff117 M
RentAndLandingFees-5 M-5 M-6 M-6 M-7 M-7 M
Research & development expense22 M19 M29 M46 M57 M56 M72 M59 M196 M85 M
ResearchExpense22 M19 M29 M46 M57 M56 M72 M59 M196 M85 M
SalariesAndWages-12 M-25 M-33 M-31 M-32 M-32 M-34 M-9 M-9 M-10 M
Selling Gen & administrative expense63 M107 M139 M153 M161 M177 M201 M194 M199 M255 M
SellingAndMarketingExpense63 M107 M139 M153 M161 M177 M201 M
SellingExpense63 M107 M139 M153 M161 M177 M201 M
Special income/charges303000.0100000.04 M100000.0-199 M
Total Income available for interest expense (EBIT)-57 M-5 M10 M-31 M-24 M22 M5 M38 M78 M16 M
Total common shares outstanding34 M36 M37 M38 M41 M41 M42 M44 M45 M46 M
Total net income-64 M-14 M2 M-38 M-43 M-471000.0-11 M146 M42 M16 M
Total ordinary shares46 M46 M46 M46 M46 M46 M46 M46 M46 M46 M
Total revenues86 M198 M249 M276 M287 M3 M421 M430 M542 M667 M
TotalExpenses-194 M-280 M-311 M-418 M-399 M-408 M172 M266 M452 M408 M
TotalRevenue82 M194 M244 M270 M284 M337 M421 M430 M542 M667 M
WriteOff199 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today